First Tracks Biotherapeutics Inc(TRAX)
$44.46-0.04 (-0.09%)
TRAX
First Tracks Biotherapeutics Inc financials statements
$44.46
At close:-0.04 (-0.09%)
Want to see TRAX full AI Analyst Report?
First Tracks Biotherapeutics Inc (TRAX) Income Statement
57 Followers
First Tracks Biotherapeutics Inc Income Statement
Last quarter (Q3 2026), First Tracks Biotherapeutics Inc's total revenue was $0.00. In Q3, First Tracks Biotherapeutics Inc's net income was $-31.36M. See First Tracks Biotherapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -139.61M | $ -152.34M | $ 0.00 | |
| $ 39.39M | $ 28.76M | $ 118.46M | |
| Depreciation and Amortization | $ 2.42M | $ 2.40M | $ 2.38M |
| $ -176.58M | $ -178.70M | $ -116.08M | |
| $ -179.01M | $ -181.10M | $ -118.46M | |
| $ 12.92M | $ 17.40M | $ 12.31M | |
| $ -166.09M | $ -163.71M | $ -106.15M | |
| $ -166.09M | $ -163.71M | $ -106.15M | |
| Per Share Metrics | |||
| Basic EPS | $ 0.00 | $ 0.00 | $ -3.05 |
| Diluted EPS | $ 0.00 | $ 0.00 | $ -3.05 |
| Weighted Average Shares Outstanding | 34.75M | 34.75M | 34.75M |
| Weighted Average Shares Outstanding (Diluted) | 34.75M | 34.75M | 34.75M |
Currency in USD

